Pharma-Bio Serv (PBSV) EBITDA (2010 - 2026)
Pharma-Bio Serv (PBSV) reported EBITDA of $144676.0 for Q2 2026, up 247.15% year-over-year from $41675.9 in Q2 2025, and up 253.04% on a QoQ basis from -$94535.0 in Q1 2026.
Pharma-Bio Serv (PBSV) EBITDA (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's EBITDA history runs 17 years deep, the most recent figure standing at $144676.0 for Q2 2026.
- EBITDA for Q2 2026 came in at $144676.0, up 247.15% year-over-year; the trailing twelve-month figure through Apr 2026 was -$397008.0 (up 45.35% YoY), and the FY2025 annual result was -$637662.0, up 50.48% from the prior year.
- EBITDA came in at $144676.0 for Q2 2026 at Pharma-Bio Serv, up from -$94535.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $460466.0 in Q3 2023 to a low of -$438300.0 in Q1 2024.
- A 5-year average of $23180.4 and a median of -$71978.0 in 2023 frame the typical range for EBITDA.
- Across the five-year window, EBITDA plunged 233.37% in 2024 and jumped 247.15% in 2026, its largest moves.
- Over 5 years, EBITDA stood at $168962.0 in 2022, then plunged by 130.64% to -$51765.0 in 2023, then sank by 197.75% to -$154130.0 in 2024, then climbed by 13.53% to -$133272.0 in 2025, then soared by 208.56% to $144676.0 in 2026.
- The last three EBITDA figures came in at $144676.0 (Q2 2026), -$94535.0 (Q1 2026), and -$133272.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 232.98 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 121.45 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 102.95 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 34.80 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -17.05 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 24.83 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 87.47 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 7.57 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 16.85 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 144,676.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 144,676.00 |
| Jan 31, 2026 | -94,535.00 |
| Oct 31, 2025 | -133,272.00 |
| Jul 31, 2025 | -313,877.00 |
| Apr 30, 2025 | -98,322.00 |
| Jan 31, 2025 | -92,191.00 |
| Oct 31, 2024 | -154,130.00 |
| Jul 31, 2024 | -381,782.00 |
| Apr 30, 2024 | -313,375.00 |
| Jan 31, 2024 | -438,300.00 |
| Oct 31, 2023 | -51,765.00 |
| Jul 31, 2023 | 460,466.00 |
| Apr 30, 2023 | 380,078.00 |
| Jan 31, 2023 | 328,632.00 |
| Oct 31, 2022 | 168,962.00 |
| Jul 31, 2022 | 369,505.00 |
| Apr 30, 2022 | 280,630.00 |
| Jan 31, 2022 | 355,848.00 |
| Oct 31, 2021 | -4.80 Mn |
| Jul 31, 2021 | 360,490.00 |